ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
24.78
0.00 (0.00%)
Oct 5, 2025, 8:00 PM EDT
ResMed Employees
ResMed had 10,600 employees as of June 30, 2025. The number of employees increased by 620 or 6.21% compared to the previous year.
Employees
10,600
Change (1Y)
620
Growth (1Y)
6.21%
Revenue / Employee
$485,503
Profits / Employee
$132,144
Market Cap
41.06B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10,600 | 620 | 6.21% |
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Jushi Holdings | 1,234 |
| Nuo Therapeutics | 9 |
ResMed News
- 4 days ago - Top 50 High-Quality Dividend Growth Stocks For October 2025 - Seeking Alpha
- 5 days ago - Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Nasdaq
- 12 days ago - Zacks.com featured highlights include GE Aerospace, ResMed, Vertiv and National Fuel Gas - Nasdaq
- 13 days ago - Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns - Nasdaq
- 14 days ago - ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 19 days ago - ResMed (RMD) Receives 'Buy' Rating from Citigroup with $330 Price Target | RMD Stock News - GuruFocus
- 20 days ago - Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025 - GlobeNewsWire
- 4 weeks ago - The sleep economy is 'having a moment', says medical equipment firm Resmed - CNBC